Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 3,877 | 3,819 | -- | -- |
| Gross Profit | -3,877 | -3,819 | -- | -- |
| Selling General And Administration | 5.2M | 6.2M | 7.7M | 4.3M |
| General And Administrative Expense | 5.2M | 6.2M | 7.7M | 4.3M |
| Research And Development | -- | 0.00 | 17,335 | 5,000 |
| Other Operating Expenses | 6.2M | 5.0M | 1.3M | 2.7M |
| Operating Expense | 11.3M | 11.2M | 9.1M | 7.0M |
| Operating Income | -11.4M | -11.2M | -9.1M | -7.0M |
| EBIT | -10.6M | 13.3M | -8.6M | -8.7M |
| Interest Expense | 861,123 | 140,882 | 277,441 | 1.1M |
| Interest Expense Non Operating | 861,123 | 140,882 | 277,441 | 1.1M |
| Interest Income | 513,693 | 637,812 | 0.00 | -- |
| Interest Income Non Operating | 513,693 | 637,812 | 0.00 | -- |
| Net Interest Income | -347,430 | 496,930 | -277,441 | -1.1M |
| Other Income Expense | 255,385 | 23.9M | 531,570 | -1.8M |
| Other Non Operating Income Expenses | 24,670 | 18,845 | 172,149 | 315,972 |
| Special Income Charges | -378,538 | 24.0M | 452,698 | -2.1M |
| Restructuring And Mergern Acquisition | -- | -- | -- | 0.00 |
| Gain On Sale Of Security | 609,253 | -53,501 | -93,277 | 33,330 |
| Pretax Income | -11.4M | 13.2M | -8.9M | -9.9M |
| Tax Effect Of Unusual Items | 0.00 | 9.6M | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -11.4M | 13.2M | -8.9M | -9.9M |
| Net Income From Continuing Operation Net Minority Interest | -11.4M | 13.2M | -8.9M | -9.9M |
| Net Income Including Noncontrolling Interests | -11.4M | 13.2M | -8.9M | -9.9M |
| Net Income Common Stockholders | -11.4M | 13.2M | -8.9M | -9.9M |
| Net Income | -11.4M | 13.2M | -8.9M | -9.9M |
| EBITDA | -10.6M | 13.3M | -8.6M | -8.7M |
| Normalized EBITDA | -10.8M | -10.6M | -8.9M | -6.6M |
| Reconciled Depreciation | 3,877 | 3,819 | 0.00 | -- |
| Basic EPS | -0.75 | 1.50 | -1.50 | -3.00 |
| Diluted EPS | -0.75 | 1.50 | -1.50 | -3.00 |
| Basic Average Shares | 13.6M | 10.7M | 6.9M | 3.3M |
| Diluted Average Shares | 13.6M | 10.7M | 6.9M | 3.3M |
| Total Unusual Items | 230,715 | 23.9M | 359,421 | -2.1M |
| Total Unusual Items Excluding Goodwill | 230,715 | 23.9M | 359,421 | -2.1M |
| Tax Rate For Calcs | 0.00 | 0.40 | 0.00 | 0.00 |
| Normalized Income | -11.7M | -1.2M | -9.2M | -7.8M |
| Diluted NI Availto Com Stockholders | -11.4M | 13.2M | -8.9M | -9.9M |
| Gain On Sale Of Ppe | 0.00 | 2.0M | 0.00 | -- |
| Impairment Of Capital Assets | 378,605 | -22.0M | 0.00 | 2.1M |
| Net Income Continuous Operations | -11.4M | 13.2M | -8.9M | -9.9M |
| Net Non Operating Interest Income Expense | -347,430 | 496,930 | -277,441 | -1.1M |
| Other Gand A | 5.2M | 3.8M | 5.2M | 2.5M |
| Other Special Charges | -67.00 | -18,845 | -452,698 | -- |
| Reconciled Cost Of Revenue | 3,877 | 3,819 | -- | -- |
| Salaries And Wages | 0.00 | 2.4M | 2.6M | 1.8M |
| Total Expenses | 11.4M | 11.2M | 9.1M | 7.0M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 1.4M | 2.6M | 4.3M | 4.8M |
| Cash Cash Equivalents And Short Term Investments | 1.4M | 2.7M | 4.4M | 4.9M |
| Cash Financial | 1.4M | 2.6M | 4.3M | 4.8M |
| Other Short Term Investments | 34,563 | 42,443 | 45,508 | 88,368 |
| Accounts Receivable | 49,685 | 43,488 | 9,094 | 19,649 |
| Receivables | 49,685 | 43,488 | 9,094 | 19,649 |
| Prepaid Assets | 1.0M | 1.6M | 477,719 | 344,693 |
| Current Assets | 2.5M | 4.3M | 4.8M | 5.3M |
| Net PPE | 61.1M | 56.5M | 17.1M | 13.6M |
| Other Non Current Assets | 16.5M | 14.4M | 14.0M | 13.0M |
| Total Non Current Assets | 77.5M | 71.0M | 31.2M | 26.5M |
| Total Assets | 80.0M | 75.3M | 36.0M | 31.8M |
| Current Debt | 5.9M | -- | -- | -- |
| Current Debt And Capital Lease Obligation | 5.9M | -- | -- | -- |
| Accounts Payable | 760,631 | 306,805 | 45,023 | 727,654 |
| Payables | 984,120 | 408,246 | 242,548 | 873,907 |
| Payables And Accrued Expenses | 1.9M | 657,712 | 242,548 | 913,907 |
| Current Accrued Expenses | 890,780 | 249,466 | 0.00 | 40,000 |
| Other Current Liabilities | -- | -- | -- | 23.0M |
| Current Liabilities | 7.8M | 657,712 | 242,548 | 23.9M |
| Long Term Debt | 3.4M | 2.7M | -- | -- |
| Long Term Debt And Capital Lease Obligation | 3.4M | 2.7M | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 27.4M | 25.0M | 21.1M | 22.0M |
| Total Liabilities Net Minority Interest | 35.1M | 25.7M | 21.3M | 45.9M |
| Common Stock | 110.5M | 107.2M | 89.3M | 60.0M |
| Capital Stock | 110.5M | 107.2M | 89.3M | 60.0M |
| Retained Earnings | -84.5M | -73.6M | -88.7M | -79.8M |
| Gains Losses Not Affecting Retained Earnings | 4.5M | 1.1M | 1.2M | 572,020 |
| Common Stock Equity | 44.9M | 49.6M | 14.7M | -14.1M |
| Stockholders Equity | 44.9M | 49.6M | 14.7M | -14.1M |
| Total Equity Gross Minority Interest | 44.9M | 49.6M | 14.7M | -14.1M |
| Total Capitalization | 48.3M | 52.3M | 14.7M | -14.1M |
| Net Tangible Assets | 44.9M | 49.6M | 14.7M | -14.1M |
| Tangible Book Value | 44.9M | 49.6M | 14.7M | -14.1M |
| Working Capital | -5.3M | 3.6M | 4.6M | -18.6M |
| Invested Capital | 54.2M | 52.3M | 14.7M | -14.1M |
| Total Debt | 9.3M | 2.7M | -- | -- |
| Net Debt | 7.9M | 91,873 | -- | -- |
| Share Issued | 13.8M | 13.3M | 8.7M | 4.1M |
| Ordinary Shares Number | 13.8M | 13.3M | 8.7M | 4.1M |
| Current Notes Payable | 5.9M | 0.00 | -- | 0.00 |
| Dueto Related Parties Current | 223,489 | 101,441 | 197,525 | 146,253 |
| Foreign Currency Translation Adjustments | 4.5M | 1.1M | 1.2M | 572,020 |
| Long Term Provisions | 24.0M | 22.3M | 21.1M | 22.0M |
| Non Current Deferred Assets | 0.00 | 112,740 | 0.00 | -- |
| Other Equity Interest | 14.4M | 14.8M | 13.0M | 5.1M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -8.1M | -7.3M | -7.9M | -4.9M |
| Cash Flow From Continuing Operating Activities | -8.1M | -7.3M | -7.9M | -4.9M |
| Depreciation And Amortization | 3,877 | 3,819 | 0.00 | -- |
| Depreciation Amortization Depletion | 3,877 | 3,819 | 0.00 | -- |
| Stock Based Compensation | 0.00 | 2.4M | 2.6M | 1.8M |
| Change In Working Capital | 2.3M | -686,856 | -365,849 | -1.1M |
| Change In Receivables | -6,197 | -34,394 | 10,555 | -6,511 |
| Change In Payables And Accrued Expense | 1.8M | 486,009 | -218,661 | -979,579 |
| Change In Payable | 1.8M | 486,009 | -218,661 | -979,579 |
| Other Non Cash Items | 1.8M | 1.9M | -1.3M | 2.2M |
| Capital Expenditure | -136,633 | -5.9M | -1.6M | -50,000 |
| Purchase Of PPE | -136,633 | -5.9M | -1.6M | -50,000 |
| Net PPE Purchase And Sale | -136,633 | -3.9M | -1.6M | 75,350 |
| Purchase Of Business | 0.00 | -112,740 | 0.00 | -- |
| Investing Cash Flow | -938,377 | -4.6M | -1.6M | -3.2M |
| Cash Flow From Continuing Investing Activities | -938,377 | -4.6M | -1.6M | -3.2M |
| Issuance Of Debt | 7.4M | 3.7M | 0.00 | -- |
| Repayment Of Debt | -1.6M | 0.00 | 0.00 | -24,916 |
| Net Issuance Payments Of Debt | 5.7M | 3.7M | 0.00 | -24,916 |
| Issuance Of Capital Stock | 0.00 | 6.5M | 20.1M | 3.9M |
| Net Common Stock Issuance | 0.00 | 6.5M | 20.1M | 3.9M |
| Financing Cash Flow | 7.8M | 10.2M | 8.9M | 11.2M |
| Cash Flow From Continuing Financing Activities | 7.8M | 10.2M | 8.9M | 11.2M |
| Changes In Cash | -1.3M | -1.7M | -531,625 | 3.1M |
| Beginning Cash Position | 2.6M | 4.3M | 4.8M | 1.8M |
| End Cash Position | 1.4M | 2.6M | 4.3M | 4.8M |
| Free Cash Flow | -8.2M | -13.2M | -9.5M | -5.0M |
| Asset Impairment Charge | 378,605 | -22.0M | 0.00 | 2.1M |
| Change In Account Payable | 1.7M | 530,093 | -269,933 | -497,862 |
| Change In Prepaid Assets | 518,843 | -1.1M | -157,743 | -135,916 |
| Common Stock Issuance | 0.00 | 6.5M | 20.1M | 3.9M |
| Depreciation | 3,877 | 3,819 | 0.00 | -- |
| Gain Loss On Sale Of PPE | 0.00 | -2.0M | 0.00 | -- |
| Long Term Debt Issuance | 7.4M | 3.7M | 0.00 | -- |
| Long Term Debt Payments | -1.6M | 0.00 | 0.00 | -24,916 |
| Net Business Purchase And Sale | 0.00 | -112,740 | 0.00 | -- |
| Net Foreign Currency Exchange Gain Loss | -1.2M | -123,536 | 12,028 | -9,460 |
| Net Income From Continuing Operations | -11.4M | 13.2M | -8.9M | -9.9M |
| Net Long Term Debt Issuance | 5.7M | 3.7M | 0.00 | -24,916 |
| Net Other Financing Charges | 22,906 | -- | -11.5M | 39,500 |
| Net Other Investing Changes | -801,744 | -651,838 | -- | -3.3M |
| Operating Gains Losses | -1.2M | -2.1M | 12,028 | -9,460 |
| Proceeds From Stock Option Exercised | 2.0M | 0.00 | 343,462 | 7.3M |
| Sale Of PPE | 0.00 | 2.0M | 0.00 | 125,350 |
| Unrealized Gain Loss On Investment Securities | 10,943 | 2,243 | 46,976 | 7,485 |